Bookmark

Add to MyYahoo RSS

Paraplatin, Carboplatin News

News on Paraplatin, Carboplatin (generic) continually updated from thousands of sources around the net.

10 hrs ago | Hispanic Business

OncoGenex Announces Cedar Clinical Trial Evaluating Apatorsen...

Apatorsen is a once-weekly intravenous experimental drug that is designed to inhibit production of heat shock protein 27 to disable cancer cells' defenses and overcome treatment resistance .

Comment?

Related Topix: Health, Lung Cancer

Tue Jul 08, 2014

Canada NewsWire

Oncolytics Biotech Inc. Announces Completion of Patient Enrollment in ...

The principal investigator is Tanios Bekaii-Saab, MD, associate professor and gastrointestinal oncology section chief at The Hospital and Richard J. Solove Research Institute .

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Oncolytics Biotech, Healthcare Industry, Cancer, Health, Pancreatic Cancer, Oncology

Tue Jul 01, 2014

Canada NewsWire

OncoGenex Announces Cedar Clinical Trial Evaluating Apatorsen in...

ORCAa program includes seven Phase 2 trials in tumor types where patient need is acute, including bladder, lung, pancreas and prostate cancers /CNW/ - OncoGenex Pharmaceuticals, Inc. today announced initiation of the Cedara clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating apatorsen in previously untreated ... (more)

Comment?

Related Topix: Medicine, Cancer, Health, Biotech, SONUS Pharmaceuticals, OncoGenex Pharmaceuticals, Healthcare Industry, Lung Cancer, Pancreatic Cancer

Thu Jun 26, 2014

CiteULike

Effectiveness of carboplatin and paclitaxel as first- and second-line ...

Patients with metastatic melanoma have a very unfavorable prognosis with few therapeutic options.

Comment?

Related Topix: Medicine

CiteULike

Combination of paclitaxel and carboplatin as second-line therapy for...

Patients with metastatic melanoma have very few therapy options. Based on reports of responses to paclitaxel and carboplatin , 31 patients with MM were treated with PC.

Comment?

Related Topix: Medicine, Oncology

Applied Clinical Trials

AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib...

Specifically, the combination of veliparib, carboplatin and paclitaxel will be compared to treatment with carboplatin, paclitaxel and placebo in patients with human epidermal growth factor receptor 2- negative metastatic or locally-advanced breast cancer, containing BRCA1 and/or BRCA2 gene mutations.

Comment?

Related Topix: Health, Breast Cancer, Lung Cancer

Wed Jun 18, 2014

International Business Times

Rodon Biologics Ties a Knot With Celllmid as 'Manufacturing Partner'

In a recent press release, Cellmid Ltd. has announced Rodon Biologics will be Cellmid's manufacturing partner for its latest "antibody" project.

Comment?

Related Topix: Oncology, Medicine

Wed Jun 11, 2014

CiteULike

First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

Comment?

Related Topix: Ovarian Cancer, Health, Medicine

•••
•••
•••
•••
•••
•••
•••